Results 51 to 60 of about 26,190 (208)
Thoracic Cancer, 2023 Background Thymic squamous cell carcinoma and type B3 thymoma are primary neoplasms of the anterior mediastinum that are sometimes difficult to differentiate from one another histologically.
Koichiro Kanamori +19 more
doaj +1 more source
Scientific Reports, 2022 To evaluate the value of texture analysis based on dynamic contrast enhanced MRI (DCE-MRI) in the differential diagnosis of thymic carcinoma and thymic lymphoma. Sixty-nine patients with pathologically confirmed (thymic carcinoma, n = 32; thymic lymphoma,
Jia-jia Zhu +6 more
doaj +1 more source
Total thymectomy for thymic lymphoepithelioma-like carcinoma—report of two cases
Surgical Case Reports, 2019 Background Thymic carcinoma has been classified into 12 subtypes, thymic lymphoepithelioma-like carcinoma (LELC) is a type of them, and has a pathological organization similar to that of lymphoepithelioma, an undifferentiated type of nasopharyngeal ...
Sachi Kawagishi +8 more
doaj +1 more source
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma
Thoracic Cancer, 2023 Thymic carcinoma is a highly malignant tumor and treatment options are limited. Lenvatinib, a novel multitargeted kinase inhibitor, has recently been approved for the treatment of unresectable thymic carcinoma.
Masatoshi Shimura +10 more
doaj +1 more source
Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis [PDF]
, 2015 BACKGROUND AND PURPOSE: The World Health Organization (WHO) has classified thymic carcinoma and other thymomas (types A, AB, and B) as different neoplasms.
김세훈
core +1 more source
Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
, 2021 Thymic carcinoma is a rare neoplasm with a dismal prognosis, and there are no established therapeutic regimens for metastatic or recurrent disease. Immune checkpoint inhibitors (ICIs), such as PD-1/PD-L1 antibodies, are widely approved in several human ...
Hisao Imai +2 more
core +1 more source
Adjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching Hospital. [PDF]
PLoS ONE, 2016 Thymic carcinomas are rare tumors for which surgical resection is the first treatment of choice. The role of adjuvant treatment after surgery is unknown because of limited available data.
Yen-Han Tseng +8 more
doaj +1 more source
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report
Thoracic Cancer, 2022 Advanced thymic carcinomas have limited treatment options. Recently, lenvatinib was approved for advanced thymic carcinoma treatment. However, the clinical benefit of lenvatinib re‐administration in patients with advanced thymic carcinoma who developed ...
Yuto Terashima +3 more
doaj +1 more source
Thymic Carcinoma Associated with Cerebellar Degeneration [PDF]
, 2017 We present the case of a 57-year-old man with ataxia and clinical and radiological features of cerebellar degeneration. A computed tomography showed a mediastinal mass. The patient was diagnosed of thymic carcinoma. paraneoplastic cerebellar degeneration
Rodríguez Galdeano, Mónica +7 more
core +1 more source
The challenges in diagnosis of thymic carcinoma
, 2022 Thymic Carcinoma (TC) is a rare tumor among the epithelial tumors of the thymus with a challenging diagnosis for pathologists. A case report, a 55-year-old male patient complained of coughing, chest pain, and intermittent shortness of breath for 2 weeks ...
Kusumastuti, E. H. (Etty) +3 more
core +1 more source